Patients with some types of lymphoma that become resistant to standard treatments may benefit from a therapy that University of Wisconsin–Madison researchers are evaluating after they discovered a key process that fuels the blood cancers' resistance to current drugs. Here are the details:
from Medical Xpress - latest medical and health news stories https://ift.tt/MILaxGn
